These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
379 related items for PubMed ID: 9331071
1. Somatic mutations of PTEN in glioblastoma multiforme. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R. Cancer Res; 1997 Oct 01; 57(19):4183-6. PubMed ID: 9331071 [Abstract] [Full Text] [Related]
2. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM. Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255 [Abstract] [Full Text] [Related]
3. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas. Put-Ti-Noi S, Petmitr S, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W. Oncol Rep; 2004 Jan 01; 11(1):207-11. PubMed ID: 14654927 [Abstract] [Full Text] [Related]
4. PIK3CA mutations in glioblastoma multiforme. Hartmann C, Bartels G, Gehlhaar C, Holtkamp N, von Deimling A. Acta Neuropathol; 2005 Jun 01; 109(6):639-42. PubMed ID: 15924253 [Abstract] [Full Text] [Related]
5. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions. Daido S, Takao S, Tamiya T, Ono Y, Terada K, Ito S, Ouchida M, Date I, Ohmoto T, Shimizu K. Oncol Rep; 2004 Oct 01; 12(4):789-95. PubMed ID: 15375501 [Abstract] [Full Text] [Related]
6. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Boström J, Cobbers JM, Wolter M, Tabatabai G, Weber RG, Lichter P, Collins VP, Reifenberger G. Cancer Res; 1998 Jan 01; 58(1):29-33. PubMed ID: 9426052 [Abstract] [Full Text] [Related]
7. Genetic alterations associated with glioma progression. Kleihues P, Lübbe J, Watanabe K, von Ammon K, Ohgaki H. Verh Dtsch Ges Pathol; 1994 Jan 01; 78():43-7. PubMed ID: 7534015 [Abstract] [Full Text] [Related]
8. Molecular pathogenesis of pediatric astrocytic tumors. Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N. Neuro Oncol; 2007 Apr 01; 9(2):113-23. PubMed ID: 17327574 [Abstract] [Full Text] [Related]
9. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region. Nakamura H, Yoshida M, Tsuiki H, Ito K, Ueno M, Nakao M, Oka K, Tada M, Kochi M, Kuratsu J, Ushio Y, Saya H. Oncogene; 1998 Feb 26; 16(8):1009-19. PubMed ID: 9519875 [Abstract] [Full Text] [Related]
10. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Fujisawa H, Kurrer M, Reis RM, Yonekawa Y, Kleihues P, Ohgaki H. Am J Pathol; 1999 Aug 26; 155(2):387-94. PubMed ID: 10433932 [Abstract] [Full Text] [Related]
11. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. Tohma Y, Gratas C, Biernat W, Peraud A, Fukuda M, Yonekawa Y, Kleihues P, Ohgaki H. J Neuropathol Exp Neurol; 1998 Jul 26; 57(7):684-9. PubMed ID: 9690672 [Abstract] [Full Text] [Related]
12. The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course. Jesionek-Kupnicka D, Kulczycka D, Rieske P, Szybka M, Jabłońska J, Potemski P, Kolasa P, Liberski PP, Kordek R. Pol J Pathol; 2007 Jul 26; 58(2):79-85. PubMed ID: 17715673 [Abstract] [Full Text] [Related]
13. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Liu W, James CD, Frederick L, Alderete BE, Jenkins RB. Cancer Res; 1997 Dec 01; 57(23):5254-7. PubMed ID: 9393744 [Abstract] [Full Text] [Related]
14. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Jeng YM, Hsu HC. Int J Cancer; 2003 Jul 10; 105(5):625-9. PubMed ID: 12740910 [Abstract] [Full Text] [Related]
15. Genetic analyses for predictors of radiation response in glioblastoma. Shih HA, Betensky RA, Dorfman MV, Louis DN, Loeffler JS, Batchelor TT. Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):704-10. PubMed ID: 15978739 [Abstract] [Full Text] [Related]
16. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH. Cancer Res; 1997 Oct 01; 57(19):4187-90. PubMed ID: 9331072 [Abstract] [Full Text] [Related]
17. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. Nozaki M, Tada M, Kobayashi H, Zhang CL, Sawamura Y, Abe H, Ishii N, Van Meir EG. Neuro Oncol; 1999 Apr 01; 1(2):124-37. PubMed ID: 11550308 [Abstract] [Full Text] [Related]
18. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. Lang FF, Miller DC, Koslow M, Newcomb EW. J Neurosurg; 1994 Sep 01; 81(3):427-36. PubMed ID: 8057151 [Abstract] [Full Text] [Related]
19. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M. Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179 [Abstract] [Full Text] [Related]
20. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Eoli M, Menghi F, Bruzzone MG, De Simone T, Valletta L, Pollo B, Bissola L, Silvani A, Bianchessi D, D'Incerti L, Filippini G, Broggi G, Boiardi A, Finocchiaro G. Clin Cancer Res; 2007 May 01; 13(9):2606-13. PubMed ID: 17473190 [Abstract] [Full Text] [Related] Page: [Next] [New Search]